Close the gap for routine mumps vaccination in Japan.

Human Vaccines & Immunotherapeutics
Taito Kitano

Abstract

Mumps is a vaccine-preventable disease. Because the mumps vaccine can cause aseptic meningitis in rare cases, this vaccine is not routine in Japan. This has led to low vaccine coverage and severe disease burden in Japan. The present review summarizes mumps epidemiology and vaccination and discusses effective future strategies to mitigate the current disease burden of mumps in Japan. Although a recent study reported that mumps vaccine coverage rates are improving in Japan, current coverage rates are far below the optimal rate to suppress the ongoing epidemic, which has caused an average annual financial loss of 85 billion JPY between 2000 and 2016. Recent reports have demonstrated a much lower incidence of vaccine-induced aseptic meningitis in newly developed vaccines, especially when administered at 1 year of age. Cost-effectiveness studies suggest that routinization of the currently distributed domestic vaccine would be highly cost-effective. In addition, questionnaire surveillance data suggest that the majority of the Japanese population accepts the nominal risk of the vaccine when the proper information is provided. Finally, there are some successful programs in Japan that have attained high vaccine coverage rates with finan...Continue Reading

References

Mar 17, 1990·Lancet·R M Anderson, R M May
Mar 1, 1991·The Pediatric Infectious Disease Journal·T FujinagaT Kuroume
Mar 1, 1991·The Pediatric Infectious Disease Journal·A Sugiura, A Yamada
Jan 1, 1986·Auris, Nasus, Larynx·J Kanzaki, Y Nomura
Dec 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·E B Buynak, M R Hilleman
Aug 1, 1970·American Journal of Diseases of Children·L P LevittJ O Bond
Jan 1, 1993·Epidemiologic Reviews·P E Fine
Jan 1, 1996·Sozial- Und Präventivmedizin·L ToscaniA Schlaepfer
Jul 15, 1998·International Journal of Pediatric Otorhinolaryngology·E Vartiainen, S Karjalainen
Jun 22, 1999·Health Physics·B Busby
Oct 29, 2000·Seminars in Neurology·H A Rotbart
Jun 14, 2005·Vaccine·Richard HarlingCorry van den Bosch
Nov 18, 2005·The Journal of Infection·Gary OngSuok Kai Chew
Oct 31, 2007·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·Tamie SugawaraNobuhiko Okabe
Mar 18, 2008·Lancet·Anders HviidKathrin Mühlemann
Nov 22, 2008·The Lancet Infectious Diseases·Heikki PeltolaIrja Davidkin
Feb 12, 2009·The Pediatric Infectious Disease Journal·Stanley A Plotkin
Apr 10, 2009·Vaccine·Jesús CastillaAurelio Barricarte
Sep 1, 1997·The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses·M RivièreC Leclerc
Aug 5, 2016·International Journal of Public Health·Oliver DammWolfgang Greiner
Apr 4, 2017·Acta Oto-laryngologica·Shin-Ichi UsamiKizuki Watanabe
Sep 7, 2017·The New England Journal of Medicine·Cristina V CardemilPatricia Quinlisk
Dec 14, 2017·The New England Journal of Medicine
Dec 15, 2017·The New England Journal of Medicine·Thomas MaitreNicolas Veziris
Dec 31, 2017·Pediatrics International : Official Journal of the Japan Pediatric Society·Taito KitanoSayaka Yoshida
Nov 2, 2018·Japanese Journal of Infectious Diseases·Takao OzakiSatoko Ohfuji
Dec 7, 2018·Epidemiology and Infection·Taito Kitano
Jun 19, 2019·Pediatrics International : Official Journal of the Japan Pediatric Society·Yoshihiko MorikawaYuho Horikoshi

❮ Previous
Next ❯

Citations

Jul 11, 2021·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Taito Kitano
Oct 7, 2021·Human Vaccines & Immunotherapeutics·Makoto MiyazakiNariyasu Mano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

California Medicine
J Chin
Nihon rinsho. Japanese journal of clinical medicine
Toshiaki Ihara
Journal of the American Medical Association
Annals of Internal Medicine
The New England Journal of Medicine
J Stokes
© 2022 Meta ULC. All rights reserved